Jiangsu Hengrui Pharmaceuticals shares rallied to their highest level in four years – leaping 10% to 62.04 renminbi - after ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved US biotech Biogen’s Qalsody (tofersen) to ...

World Hepatitis Day, marked each year on July 28, is shining a light on what GlobalData calls an “urgent need” for a renewed ...

Boehringer Ingelheim and Re-Vana Therapeutics, a USA and UK based developer of ocular therapeutics and ocular drug delivery ...

The information portal on the entry of new medicines and indications shows the number of new medicines and indications ...

The US Food and Drug Administration (FDA) issued a press release late Friday announcing an investigation into the death of an ...

UK pharma major AstraZeneca this morning revealed that its supplemental Biologics License Application (sBLA) for Imfinzi ...

Swiss pharma major Roche (ROG: SIX) has outlined ambitious plans to accelerate the development of trontinemab, its ...

A new European project, called Greg, has been launched to tackle long-standing challenges around the use of real-world data and evidence in medicines, medical devices, and drug-device combinations.

The BioIndustry Association (BIA) has published new data revealing that the UK’s life sciences sector attracted £1.23 billion ...

China has recently approved the first locally developed obesity drug Xinermei (mazdutide), marking a critical milestone in the country’s obesity treatment landscape.

For millions in low- and middle-income countries (LMICs), lifesaving medicines remain out of reach. While the pharmaceutical industry continues to deliver record-breaking innovation, access to those ...